PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 16 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $58,000 | -73.3% | 58,038 | -46.0% | 0.00% | – |
| Q3 2021 | $217,000 | -26.4% | 107,500 | -17.6% | 0.00% | – |
| Q2 2021 | $295,000 | +0.3% | 130,400 | +18.7% | 0.00% | – |
| Q1 2021 | $294,000 | +359.4% | 109,900 | +355.7% | 0.00% | – |
| Q4 2020 | $64,000 | – | 24,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 35,929 | $77,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 21,278 | $46,000 | 0.01% |
| UBS Group AG | 566 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HSBC HOLDINGS PLC | 11,337 | $24,000 | 0.00% |
| BlackRock Inc. | 19 | $0 | 0.00% |
| Citadel Advisors | 12,178 | $26,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 581 | $1,000 | 0.00% |